| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/22/2009 | CN101485678A Low molecular weight heparin medicament composition and preparation method thereof |
| 07/22/2009 | CN101485677A Application of medlar polysaccharide in preventing urinary calculus |
| 07/22/2009 | CN101485676A Eye drops for treating infectious conjunctivitis |
| 07/22/2009 | CN101485675A Adapalene and hydrochloric clindamycin compound gel preparation and preparation method thereof |
| 07/22/2009 | CN101485674A Application of naringin in preparing anti-depression medicament |
| 07/22/2009 | CN101485673A Roxithromycin and ambroxol hydrochloride dispersible tablets |
| 07/22/2009 | CN101485672A Application of hylotelephin in preparing medicament for treating human HBeAg-positive chronic hepatitis B |
| 07/22/2009 | CN101485671A Novel medicinal use of 8-O-acetyl shanzhiside methylester |
| 07/22/2009 | CN101485670A Application of glucopyranoside compound in preparing medicament for improving hypertensive cerebrovascular remodeling |
| 07/22/2009 | CN101485669A Medicament for treating tumor and hemorrhoid and method for producing the same |
| 07/22/2009 | CN101485668A Nutriment composite for persons in middle and old age |
| 07/22/2009 | CN101485667A Pharmaceutical use of triptolide |
| 07/22/2009 | CN101485666A Application of Gamabufotalin and salt thereof in preparing medicament for treating gynaecologic tumor |
| 07/22/2009 | CN101485665A Novel medical use of cucurbitacin |
| 07/22/2009 | CN101485664A 5HT2c receptor modulators |
| 07/22/2009 | CN101485663A Novel use of sodium ion channel antagonist compound in improving quality of human sleeping |
| 07/22/2009 | CN101485662A Medicament for treating neurasthenia |
| 07/22/2009 | CN101485661A Use of sinomenine derivates in treating autoimmune disease through antagonism TNF-alpha signaling pathway |
| 07/22/2009 | CN101485660A Anti-tumor use of alpha-(8-quinolinoxy) monosubstituted phthalocyanine zinc |
| 07/22/2009 | CN101485659A Medicament composition of amlodipine and simvastatin as well as preparation method and application thereof |
| 07/22/2009 | CN101485658A Method for preparing amoxicillin-ofloxacin suspension injection |
| 07/22/2009 | CN101485657A Diovan compound preparation and preparation method thereof |
| 07/22/2009 | CN101485656A Application of epi-gallocatechin-3-gallate in preparing medicament for preventing and treating pulmonary fibrosis |
| 07/22/2009 | CN101485655A Application of dihydromyricetin in preparing medicament for preventing and treating adverse reaction of tumor chemoradiotherapy |
| 07/22/2009 | CN101485654A Application of T-2 toxin in preparing medicament for treating solid tumor |
| 07/22/2009 | CN101485653A Application of T-2 toxin in preparing medicament for treating leukemia |
| 07/22/2009 | CN101485652A Composition of taxone compound, and preparation method and application thereof |
| 07/22/2009 | CN101485651A Dihydrochalcone derivates and use thereof |
| 07/22/2009 | CN101485650A Diclofenac sodium and lidocaine hydrochloride injection and preparation method thereof |
| 07/22/2009 | CN101485649A Application of Cajanus cajan stilbene acid and pinostrobin in Cajanus cajan leaf in preparing anti-herpesvirus medicament |
| 07/22/2009 | CN101485648A Application of 3,4-dihydroxy-phenyl-lactic acid in preparing medicament for treating microcirculatory disturbance |
| 07/22/2009 | CN101485647A Use of patchouli alcohol in preparing medicament |
| 07/22/2009 | CN100516220C Serine proteinase inhibitor of bifidobacteria |
| 07/22/2009 | CN100516203C In vitro cell culturing method |
| 07/22/2009 | CN100516066C Compounds for treating impaired fundic relaxation |
| 07/22/2009 | CN100516065C 1,3,4-oxadiazol-2-ones as PPAR-delta modulators |
| 07/22/2009 | CN100516062C New medicine |
| 07/22/2009 | CN100516061C Pyridine derivatives as NMDA receptor ligands |
| 07/22/2009 | CN100516059C Remedies |
| 07/22/2009 | CN100516047C Lactam compound |
| 07/22/2009 | CN100516041C Novel heteroaryl derivative |
| 07/22/2009 | CN100516037C Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 07/22/2009 | CN100516034C Inhibitors of aspartyl protease |
| 07/22/2009 | CN100516024C Amino-propanol derivatives |
| 07/22/2009 | CN100516018C Double esters |
| 07/22/2009 | CN100515497C Liposomal delivery of vitamin E based compounds |
| 07/22/2009 | CN100515427C self emulsifying soft capsule of breviscapine and its preparation |
| 07/22/2009 | CN100515426C Total asiaticoside gel and its preparation |
| 07/22/2009 | CN100515425C Medicine composition for preventing and treating farm animal's respiratory tract and digestive tract diseases |
| 07/22/2009 | CN100515424C Application of a kind of alpha glycosidase inhibitor in preparation of medicine to treat hyperlipemia of diabetes |
| 07/22/2009 | CN100515423C Application of a kind of alpha glycosidase inhibitor in preparation of medicine to prevent or treat diabetic microvascular complication |
| 07/22/2009 | CN100515422C Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 07/22/2009 | CN100515421C Therapeutic treatment and pharmaceutical use thereof |
| 07/22/2009 | CN100515420C Pharmaceutical compositions of tizoxanide and nitazoxanide |
| 07/22/2009 | CN100515419C Substituted benzazoles and its application as inhibitors of Raf kinase |
| 07/22/2009 | CN100515418C Methods and apparatus for improved administration of analgesics |
| 07/22/2009 | CN100515417C Applicaiton of meclofenoxate hydrochloride in preparing medicine for treating femoral head necrosis |
| 07/22/2009 | CN100515416C A herbal molecule as potential anti-leukemic drug |
| 07/22/2009 | CN100515415C Rumen protection amino acid and preparing method |
| 07/22/2009 | CN100515414C Application of honokiol in preparing medicine for treating acute leukemia |
| 07/21/2009 | USRE40862 Adrenal, ovarian, thyroid, testicular, pituitary, prostate, or breast cancer |
| 07/21/2009 | USRE40861 4-Trimethylammonium-3-(nonylcarbamoyl)-aminobutyrate; hypoglycemic agents; antidiabetic agents; antiischemic agents; congestive heart failure; obesity |
| 07/21/2009 | US7563937 Zeolite Y alkylation catalysts |
| 07/21/2009 | US7563928 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/21/2009 | US7563924 Methyl-9-chloro-11-[2H-tetrahydropyran-2-yloxy]-17,17-tetramethylene-20-nor-5,13-prostadienoate; EP2 receptor agonists with greater selectivity and stability; reducing release of Th-1 cytokines; promoters of fertility, in vitro fertilization, ovulation, cumulus expansion; intraocular depressurization |
| 07/21/2009 | US7563922 catalytic chemical preparation of intermediate 4-(2-cyanoethenyl)-2,6-dimethylbenzenamine stereoisomers in presence of palladium chloride; having HIV inhibiting properties |
| 07/21/2009 | US7563921 chemical preparation of a chemical intermediates for making pesticides in agriculture use; protection of seeds, plant's roots from soil insects, acarina |
| 07/21/2009 | US7563913 Compound and pharmaceutical composition |
| 07/21/2009 | US7563912 new improved method for manufacturing chemical intermediate of (S)-(-)- alpha -ethyl-2-oxo-1-pyrrolidine acetamide which is used in therapy and prophylaxis epilepsy and other neurological disorders; stereospecific; industrial scale production, environmentally friendly |
| 07/21/2009 | US7563910 Heterocyclic cannabinoid receptor antagonists |
| 07/21/2009 | US7563909 Nitrate derivatives of atorvastatin with improved pharmacological activity and enhanced tolerability; coronary syndromes, neurodegenerative disorders, and for reducing cholesterol levels; antiinflammatory, antithrombotic and antiplatelet activity; fluvastatin 4-(nitrooxy)butyl ester |
| 07/21/2009 | US7563908 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI |
| 07/21/2009 | US7563906 Indazole derivatives |
| 07/21/2009 | US7563905 Triazole derivatives and method of using the same to treat HIV infections |
| 07/21/2009 | US7563903 Acylaminothiazole derivatives, their preparation and their therapeutic use |
| 07/21/2009 | US7563901 potent antimicrobial activity and a wide antimicrobial spectrum in a safe and cost effective reaction |
| 07/21/2009 | US7563896 Process of obtaining type II dehydroquinase enzyme inhibitors and precursors thereof |
| 07/21/2009 | US7563894 e.g. [2-(4-Isopropyl-piperazin-1-yl)-benzooxazol-6-yl]-[5-(4-methoxy-phenyl)-pyrimidin-2-yl]-amine; C-kit kinase receptor or stem cell factor inhibitors; anticarcinogenic agents; veterinary medicine |
| 07/21/2009 | US7563893 3-Phenyl-cinnoline analogue and antitumor agent using the same |
| 07/21/2009 | US7563892 Autoimmune diseases; water solubility of prodrug can be tailored to improve bioavailability using substution at amine groups; inhibitors of degranulation of immune cells; inhibit/activate Fc receptor signaling cascades; treatment of pyridinediamine compound with base, then acid |
| 07/21/2009 | US7563891 Long wavelength thiol-reactive fluorophores |
| 07/21/2009 | US7563884 Antisense modulation of PTP1B expression |
| 07/21/2009 | US7563871 Polymer-based sustained release device |
| 07/21/2009 | US7563823 Modified release formulations of a bupropion salt |
| 07/21/2009 | US7563822 active ingredient a 5-amidino-2-hydroxybenzenesulfonamide derivative or a pharmaceutical acceptable salt thereof; excellent inhibitory effect on mesangial cell proliferation and decreasing effect on urine protein excretion |
| 07/21/2009 | US7563821 Levodopa prodrug mesylate, compositions thereof, and uses thereof |
| 07/21/2009 | US7563820 Administering strylacrylonitrile compound; antiproliferative agents; anticancer agents |
| 07/21/2009 | US7563819 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 07/21/2009 | US7563818 Metallic core linked by a mercaptoalkyl tether to a monolayer of zinc phthalocyanine complex capable of photo-excitation to produce singlet oxygen; and phase transfer reagent; photodynamic therapy; reduction of chloroauric acid |
| 07/21/2009 | US7563817 Purified 2-aryl-3,3-bis(hydroxyaryl)phthalimidines |
| 07/21/2009 | US7563816 Ophthalmic compositions for treating ocular hypertension |
| 07/21/2009 | US7563815 Benzamidazoles, compositions containing such compounds and methods of use |
| 07/21/2009 | US7563814 Olmesartan medoxomil with reduced levels of impurities |
| 07/21/2009 | US7563813 Iminothiazolidinone derivatives as SFRP-1 antagonists |
| 07/21/2009 | US7563812 Amorphous esomeprazole hydrate |
| 07/21/2009 | US7563811 3-(2-Cyanophenyl)-5-(2-methoxyphenyl)-1-phenyl-1,2-dihydropyridin-2-one; antagonists of AMPA and kainate receptors; neuroprotectants; neurodegenerative diseases; Alzheinmer's disease; antiepileptic agents; antispasmodic agents; anxiolytic agents; ddrug abuse; nervous sytem disorders; antihypoxic agents |
| 07/21/2009 | US7563810 Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases |
| 07/21/2009 | US7563809 Nociceptin analogs |
| 07/21/2009 | US7563808 administering a cholinesterase inhibitor ( a dimethoxyindanone derivative) to treat dementia associated with or caused by vascular diseases |
| 07/21/2009 | US7563807 Removal of aldehyde impurity by reactive polystyrene resini |